Growing investment in rare disease R&D, gene editing technologies, and supportive care innovations are driving global growth in the Fanconi anemia treatment market to address marrow failure and congenital DNA repair deficiencies. https://www.datamintelligence.com/research-report/fanconi-anemia-market